Treatment of methicillin-resistant Staphylococcus aureus in Latin America

被引：0

作者：

Luna, Carlos M. ^{[1
]}

Rodriguez-Noriega, Eduardo ^{[2
]}

Bavestrello, Luis ^{[3
]}

Gotuzzo, Eduardo ^{[4
]}

机构：

[1] Univ Buenos Aires, Dept Internal Med, Hosp Clin, Div Pulm Dis, RA-1425 Buenos Aires, DF, Argentina

[2] Univ Guadalajara, Ctr Univ Ciencias Salud, Inst Patol Infecciosa & Expt, Hosp Civil Guadalajara, Guadalajara, Jalisco, Mexico

[3] Clin Renaca, Vina Del Mar, Chile

[4] Univ Peruana Cayetano Heredia, Lima, Peru

来源：

BRAZILIAN JOURNAL OF INFECTIOUS DISEASES | 2010年 / 14卷

关键词：

MRSA; treatment; antibiotic therapy; Latin America; HOSPITAL-ACQUIRED PNEUMONIA; SOFT-TISSUE INFECTIONS; INADEQUATE ANTIMICROBIAL TREATMENT; INDUCIBLE CLINDAMYCIN RESISTANCE; VENTILATOR-ASSOCIATED PNEUMONIA; COMPLICATED SKIN; TRIMETHOPRIM-SULFAMETHOXAZOLE; QUINUPRISTIN-DALFOPRISTIN; VANCOMYCIN RESISTANCE; NECROTIZING FASCIITIS;

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The global spread of methicillin-resistant Staphylococcus aureus (MRSA) means it is now a pathogen of worldwide public health concern. Within Latin America, MRSA is highly prevalent, with the proportion of S. aureus isolates that are methicillin-resistant on the rise, yet resources for managing the infection are limited. While several guidelines exist for the treatment of MRSA infections, many are written for the North American or European setting and need adaptation for use in Latin America. In this article, we aim to emphasize the importance of appropriate treatment of MRSA in the healthcare and community settings of Latin America. We present a summary of the available guidelines and antibiotics, and discuss particular considerations for clinicians treating MRSA in Latin America.

引用

页码：S119 / S127

页数：9

共 78 条

[1] Staphylococcal Surgical Site Infections
Anderson, Deverick J.
Kaye, Keith S.
[J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2009, 23 (01) : 53 - +
[2] Guidelines for the management, of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia
不详
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (04) : 388 - 416
[3] The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections
Arbeit, RD
Maki, D
Tally, FP
Campanaro, E
Eisenstein, BI
[J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 (12) : 1673 - 1681
[4] The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: Analysis of pooled clinical trial data
Babinchak, T
Ellis-Grosse, E
Dartois, N
Rose, GM
Loh, E
[J]. CLINICAL INFECTIOUS DISEASES, 2005, 41 : S354 - S367
[5] Baudel Jean-Luc, 2009, Ther Clin Risk Manag, V5, P491
[6] Epidemiology of methicillin-resistant Staphylococcus aureus
Boucher, Helen W.
Corey, G. Ralph
[J]. CLINICAL INFECTIOUS DISEASES, 2008, 46 : S344 - S349
[7] Perspectives on daptomycin resistance, with emphasis on resistance in Staphylococcus aureus
Boucher, Helen W.
Sakoulas, George
[J]. CLINICAL INFECTIOUS DISEASES, 2007, 45 (05) : 601 - 608
[8] Combating the growing problem of methicillin-resistant Staphylococcus aureus:: do the newer antibiotics represent a better alternative to vancomycin?
Chambers, Henry F.
Hegde, Sharath S.
[J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2007, 5 (03) : 333 - 335
[9] The changing epidemiology of Staphylococcus aureus?
Chambers, HF
[J]. EMERGING INFECTIOUS DISEASES, 2001, 7 (02) : 178 - 182
[10] Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene
Chang, S
Sievert, DM
Hageman, JC
Boulton, ML
Tenover, FC
Downes, FP
Shah, S
Rudrik, JT
Pupp, GR
Brown, WJ
Cardo, D
Fridkin, SK
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) : 1342 - 1347

← 1 2 3 4 5 6 7 8 →